Please note that the list of Invited Speakers is subject to change, and will be updated continuously.
Professor, Emerging Viral Disease Program at Duke-NUS Medical School. His current research is focused on understanding the impact of age in HBV infection/pathology and on the development of new immunological based therapies (TCR-redirected T cells, HLA-peptide specific antibodies) for the treatment of HBV and Hepatocellularcarcinoma.
Professor at the Hepatitis Research Center, National Taiwan University Hospital. His areas of expertise and research interests include Molecular Biology of Hepatitis Viruses, Liver carcinogenesis, prevention and treatment of chronic viral hepatitis.
Lim Seng Gee
Prof Lim is Director of Hepatology, Dept of Gastroenterology & Hepatology National University Hospital, Chairman of the Singapore Hepatitis Conference, Governing Council Member, International Association for Study of Liver; and Adjunct Principal Investigator, Institute of Molecular and Cell Biology, ASTAR
Prof Locarnini is a Head of Department at Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, University of Melbourne, WHO Regional Reference Laboratory for Hepatitis B. His research interests include Hepatitis A, B, C, D, E, public health, co-infection with HIV, pathogenesis, cure strategies.
Professor at Department of Infectious Diseases, Molecular Virology, University Heidelberg. His research interests include molecular mechanisms of Hepatitis B and Hepatitis D Virus/host interactions with a focus on the early events of infection and development of hepatotropic drugs for the therapy of liver diseases